Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Argos Therapeutics Inc. (ARGS)

0.15 0.001 (0.67%)

10-23 11:02

Open:

0.1426

Pre. Close:

0.149

High:

0.158

Low:

0.1426

Volume:

21,394

Market Cap:

2M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.15 - 0.151

0.151 - 0.152

Low:

0.148 - 0.149

0.149 - 0.15

Close:

0.149 - 0.15

0.15 - 0.152

Technical analysis  (as of: 2018-10-23 2:49:14 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.22     One year: 0.29

Support:

Support1: 0.08    Support2: 0.07

Resistance:

Resistance1: 0.19    Resistance2: 0.25

Pivot:

0.16

Moving Averages:

MA(5): 0.15     MA(20): 0.15

MA(100): 0.14     MA(250): 1.18

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 38.18     %D(3): 40.27

RSI:

RSI(14): 50.85

52-Week:

High: 5.8  Low: 0.075  Change(%): -95.5

Average Vol(K):

3-Month: 5414  10-Days 11197

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ARGS has closed above bottom band by 39.3%. Bollinger Bands are 163.4% wider than normal. The large width of the bands suggest high volatility as compared to ARGS's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

2018-04-23T06:42:56-04:00
Biotech Analysis Central Pharma News: Biogen's Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out

2018-04-22T10:44:44-04:00
3 Things In Biotech, April 21: Solid Stands, Argos Stops, NewLink Strives

2018-04-20T08:00:00-04:00
Your Daily Pharma Scoop: Adamas Update, Shire Bidding War, Novartis Results

2018-04-19T12:40:25-04:00
Midday Gainers / Losers (04/19/2018)

2018-04-19T09:24:36-04:00
Premarket Losers as of 9:05 am (04/19/2018)

2018-04-19T09:04:21-04:00
Argos Therapeutics bails on late-stage study of Rocapuldencel-T in kidney cancer; shares down 64%

2018-04-02T08:34:41-04:00
Argos Therapeutics reports Q4 results

2018-02-15T09:21:15-05:00
Premarket Gainers as of 9:05 am (02/15/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

7.91

Shares Float (M)

6.37

% Held by Insiders

% Held by Institutions

0.10

Shares Short (K)

649

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

-1.190

EPS Est. Next Year

-0.480

EPS Est. Next Quarter

-0.200

Forward EPS

1.#IO

Book Value (p.s.)

2.880

PEG Ratio

Profit Margin

Operating Margin

-271.20

Return on Assets (ttm)

-61.6

Return on Equity (ttm)

3695.6

Qtrly Rev. Growth

-22.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-22.06

Levered Free Cash Flow (M)

-7.43

Valuation

P/E

P/E Growth Ratio

P/BV

0.05

P/S

1346186.50

P/CF

-0.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2018-01-19

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.